[The difficult choice: when not to treat. Hormone-refractory metastatic prostate cancer]

Suppl Tumori. 2004 Jul-Aug;3(4):S93.
[Article in Italian]
No abstract available

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • Clinical Trials, Phase III as Topic
  • Drug Resistance, Neoplasm
  • Humans
  • Male
  • Medical Futility*
  • Neoplasm Metastasis
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / therapy*
  • Randomized Controlled Trials as Topic

Substances

  • Antineoplastic Agents, Hormonal